Cancer therapy with decreased SARS-CoV-2 infection rates in cancer patients

被引：4
|
作者：
Hayashi, Takuma [1 ,2 ]
Konishi, Ikuo [1 ,3 ]
机构：
[1] Natl Hosp Org, Kyoto Med Ctr, Kyoto, Japan
[2] Japan Sci & Technol Agcy JST, START Program, Tokyo, Japan
[3] Kyoto Univ, Grad Sch Med, Kyoto, Japan
来源：
BRITISH JOURNAL OF CANCER | 2022年 / 126卷 / 04期
基金：
日本科学技术振兴机构; 日本学术振兴会;
关键词：
D O I：
10.1038/s41416-021-01685-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：521 / 522
页数：2
相关论文
共 50 条
  • [21] Impacts of androgen deprivation therapy on the risks and outcomes of SARS-CoV-2 infection in patients with prostate cancer
    Huang, Yuan-Bin
    Li, Wei-Lin
    Sun, Man
    Duan, Xu
    Wang, Yu-Tong
    Zhang, Lu-Xin
    Xin, Zi-Han
    Yun, Zhi-Fei
    Fan, Bo
    Li, Xian-Cheng
    ASIAN JOURNAL OF ANDROLOGY, 2023, 25 (03) : 366 - 374
  • [22] SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines
    Di Giacomo, Anna M.
    Giacobini, Gianluca
    Anichini, Gabriele
    Gandolfo, Claudia
    D'alonzo, Vincenzo
    Calabro, Luana
    Lofiego, Maria F.
    Cusi, Maria G.
    Maio, Michele
    EUROPEAN JOURNAL OF CANCER, 2022, 171 : 143 - 149
  • [23] Long-term consequences of SARS-CoV-2 infection in cancer patients
    Debie, Y.
    Palte, Z.
    Salman, H.
    Verbruggen, L.
    Vanhoutte, G.
    Raats, S.
    Roelant, E.
    Vandamme, T.
    Peeters, M.
    van Dam, P. A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1125 - S1125
  • [24] Risk factors for hospitalization for cancer patients with SARS-CoV-2 infection.
    Shahid, Zainab
    Baldrige, Emily
    Trufan, Sally
    Schepel, Courtney
    Tan, Antoinette R.
    Hwang, Jimmy J.
    Musselwhite, Laura W.
    Kim, Edward S.
    Chai, Seungjean
    Sumrall, Ashley Love
    Ragon, Brittany K.
    Voorhees, Peter Michael
    Grunwald, Michael Richard
    Ghosh, Nilanjan
    Usmani, Saad Zafar
    Copelan, Edward Alan
    Raghavan, Derek
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [25] Tumor marker response to SARS-CoV-2 infection among patients with cancer
    Gunn, Alexander H.
    Tashie, Carolyn
    Wolf, Steven
    Troy, Jesse D.
    Zafar, Yousuf
    CANCER MEDICINE, 2022, 11 (14): : 2865 - 2872
  • [26] CARDIOVASCULAR COMPLICATIONS IN HOSPITALIZED PATIENTS WITH SARS-COV-2 INFECTION AND HISTORY OF CANCER
    Siddiqi, Hasan
    Vieira, Jefferson
    Zhou, Guohai
    Weber, Brittany
    Kim, Andy
    Rutherford, Henry
    Varshney, Anubodh
    Bhatt, Ankeet
    Woolley, Ann
    Nohria, Anju
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 3097 - 3097
  • [27] Determinants of mortality from SARS-CoV-2 infection in European cancer patients
    Pinato, D. J.
    Sng, C.
    Wong, Y. N. S.
    Biello, F.
    Segui, E.
    Aguilar-Company, J.
    Carbo Bague, A.
    Patriarca, A.
    Bower, M. D.
    Rizzo, G.
    Bruna, R.
    Cruz, C. A.
    D'Avanzo, F.
    Newsom-Davis, T.
    Molla, M.
    Gaidano, G.
    Brunet, J.
    Tabernero, J.
    Prat, A.
    Gennari, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S995 - S995
  • [28] PARIS score for evaluation of probability of SARS-CoV-2 infection in cancer patients
    Candice Gueuning
    Lieveke Ameye
    Angela Loizidou
    Bogdan Grigoriu
    Anne-Pascale Meert
    Supportive Care in Cancer, 2022, 30 : 7635 - 7643
  • [29] Outcomes by race for cancer patients hospitalized with SARS-CoV-2 infection.
    Chang, Steven S.
    Hwang, Clara
    Elshaikh, Mohamed A.
    Tang, Amy
    Neslund-Dudas, Christine M.
    Levin, Albert M.
    Poisson, Laila M.
    Rybicki, Benjamin A.
    CLINICAL CANCER RESEARCH, 2020, 26 (18)
  • [30] SARS-CoV-2 Infection in Cancer Patients: A Population-Based Study
    Zorzi, Manuel
    Guzzinati, Stefano
    Avossa, Francesco
    Fedeli, Ugo
    Calcinotto, Arianna
    Rugge, Massimo
    FRONTIERS IN ONCOLOGY, 2021, 11
12345